Journal of Internal Medicine 2006; 260: 601-605 Author index van Aalst-Cohen, E.S. see Rana, J.S. Ceppa, P. see Testa, R. Aasa, M. see Jensen, J. Cesari, M., Pessina, A.C., Zanchetta, M., De Toni, R., Avogaro, A.., Abildgaard, U. see Njaastad, A.M. Pedon, L., Dorigatti, F., Maiolino, G. & Rossi, G.P. Low plasma Abou-Raya, A. see Abou-Raya, S. adiponectin is associated with coronary artery disease but Abou-Raya, S. & Abou-Raya, A. Spinal tuberculosis: overlooked?, not with hypertension in high-risk nondiabetic patients, 474 160 Chandler, J. see Lips, P. Adami, H.-O. see Dickman, P.W. Chang, W.-Y. see Huang, J.-F. Adami, H.-O. see Lu, M. Chen, S.-C. see Huang, J.-F. Agarwal, A.K., Silver, M.R., Reed, J.E., Dhingra, R.K., Liu, W., Christ, E.R. see Stettler, C. Varma, N. & Stehman-Breen, C. An open-label study of Christ, M. see Mueller, C. darbepoetin alfa administered once monthly for the main- Christ-Crain, M. see Miiller, B. tenance of haemoglobin concentrations in patients with Christiansen, J.S. see Norrelund, H. chronic kidney disease not receiving dialysis, 577 Chuang, W.-L. see Huang, J.-F. Allemann, S. see Stettler, C. Claesson, M., Birgander, L.S., Jansson, J.-H., Lindahl, B., Burell, Almquist, T., Forslund, L., Rehnqvist, N. & Hjemdahl, P. G., Asplund, K. & Mattsson, C. Cognitive-behavioural stress Prognostic implications of renal dysfunction in patients with management does not improve biological cardiovascular risk stable angina pectoris, 537 indicators in women with ischaemicheart disease: a rando- Andersson, C. see Norberg, M. mized-controlled trial, 320 Angelin, B. see Lundasen, T. Cleland, J.G.F. see Loh, P.H. Angquist, K.-A. see Herlitz, J. Cohen, P. see Fontaine, A. Asakawa, A. see Inui, T. Coleman, C.I. see Henyan, N.N. Asplund, K. see Claesson, M. Csernok, E. see Lamprecht, P. Attvall, S. see Smith, U. Avogaro, A. see Cesari, M. Dai, C.-Y. see Huang, J.-F. Davalos, A. see Leira, R. Bauer, T.T., Ewig, S., Marre, R., Suttorp, N., Welte, T. & The De Toni, R. see Cesari, M. Capnetz Study Group. CRB-65 predicts death from commu- Dhingra, R.K. see Agarwal, A.K. nity-acquired pneumonia, 93 Dhote, R. see Fontaine, A. 3ehre, C.J., Brohall, G., Hulthe, J., Wikstrand, J. & Fagerberg, B. Dickman, P.W. & Adami, H.-O. Interpreting trends in cancer Are serum adiponectin concentrations in a population patient survival, 103 sample of 64-year-old Caucasian women with varying Diem, P. see Stettler, C. glucose tolerance associated with ultrasound-assessed Dorigatti, F. see Cesari, M. atherosclerosis?, 238 Dorkhan, M., Magnusson, M., Frid, A., Grubb, A., Groop, L. & Berg, G. see Milakovic, M. Jovinge, S. Glycaemic and nonglycaemic effects of pioglita- Bergfeldt, L. see Tabrizi, F. zone in triple oraltherapy of patients with type 2 diabetes, Berglund, G. see Nilsson, P.M. 125 Bergmann, J.-F. see Bosson, J.-L. Drevs, J. & Schneider, V. The use of vascular biomarkers and Bergmann, A. see Miiller, B. imaging studies in the early clinical development of anti- Bergmann, J.F. see Fontaine, A. tumour agents targeting angiogenesis, 517 Bhalla, A. see Singh, V. Bingisser, R. see Miiller, B. Eggertsen, R. see Milakovic, M. Birgander, L.S. see Claesson, M. Eliasson, B. see Smith, U. Bjorkhem, I. Crossing the barrier: oxysterols as cholesterol Eliasson, M., Janlert, U., Jansson, J.-H. & Stegmayr, B. Time trends transporters and metabolic modulators in the brain, 493 in population cholesterol levels 1986-2004: influence of Blanco, M. see Leira, R. lipid-lowering drugs, obesity, smoking and educational level. Blumstein, N.M. see Kriiger, S. The northern Sweden MONICA study, 551 de Boer, H. see Timmers, H.J.L.M. Engdahl, J. see Herlitz, J. Borén, J. see Smith, U. Englund, A. see Tabrizi, F. Borro, P. see Testa, R. Engstrém, G., Hedblad, B. & Janzon, L. Reduced lung function 3osson, J.-L., Pouchain, D. & Bergmann, J.-F. for The ETAPE predicts increased fatality in future cardiac events. A Study Group. A prospective observational study of a cohort of population-based study, 560 outpatients with anacute medical event and reduced Erikssen, J. see Stavem, K. mobility: incidence of symptomatic thromboembolism and Eriksson, J.W. see Norberg, M. description of thromboprophylaxispractices, 168 Ernst, E. & Pittler, M.H. Efficacy or effectiveness?, 488 30tker, H.E. see Norrelund, H. Etminan, M. see Wiens, M. Breidthardt, T. see Mueller, C. Ewig. S. see Bauer, T.T. Brohall, G. see Behre, C.]. Broliden, K., Tolfvenstam, T. & Norbeck, O. Clinical aspects of parvovirus B19 infection, 285 Fadeel, B. see Wastfelt, M. Buck, A.K. see Kriiger, S. Fagerberg, B. see Behre, C.J. Biller, H.R. see Kruip, M.J.H.A. Fiessinger, J.N. see Fontaine, A. Burell, G. see Claesson, M. Figenschau, Y. see Iqbal, A. Filippatos, G.S., Gavrielatos, G. & Kremastinos, D.T. Gains and losses during anticoagulation treatment in patients with Castellanos, M. see Leira, R. mechanical heart valves., 595 Castillo, J. see Leira, R. Fiser, I. see Marschang, P. © 2006 Blackwell Publishing Ltd 602 AUTHOR INDEX Flyvbjerg, A. see Norrelund, H. Iqbal, A., Jorde, R. & Figenschau, Y. Serum lipid levels in relation Fontaine, A., Mahé, I., Bergmann, J.F., Fiessinger, J.N., Dhote, R., to serum thyroid-stimulating hormone and the effect of Cohen, P. & Vinceneux, P. Effectiveness of written guidelines thyroxine treatment on serum lipid levels in subjects with on the appropriateness of thromboprophylaxis prescriptions subclinical hypothyroidism: the Tromso Study, 53 for medical patients: a prospective randomized study, 369 Ishikawa, H. see Satoh, H. Foreyt, J.P. see Poston, W.S.C. Isola, L. see Testa, R. Forslund, L. see Almquist, T. Iyemere, V.P., Proudfoot, D., Weissberg, P.L. & Shanahan, C.M. Frid, A. see Dorkhan, M. Vascular smooth muscle cell phenotypic plasticity and the Frystyk, J. see Norrelund, H. regulation of vascular calcification, 192 Galman, C. see Lundasen, T. Janlert, U. see Eliasson, M. Gavrielatos, G. see Filippatos, G.S. Jansen, A.C. see Rana, J.S. Gerardin, E. see Marie, I. Jansson, J.-H. see Claesson, M. Giannini, E. see Testa, R. Jansson, J.-H. see Eliasson, M. Gill, S.S. see Wiens, M. Janzon, L. see Engstrom, G. Gillespie, E.L. see Henyan, N.N. Jensen, J., Lagerqvist, B., Aasa, M., Saérev, T., Nilsson, T. & Giscombe, R., Wang, X.B., Kakoulidou, M. & Lefvert, A.K. Tornvall, P. Clinical and angiographic follow-up after Characterization of the expanded T-cell populations in coronary drug-eluting andbare metal stent implantation. Do patients with Wegener's granulomatosis, 224 drug-eluting stents hold thepromise?, 118 Groop, L. see Dorkhan, M. Jensen, J.S. see Klausen, K.P. Gross, W.L. see Lamprecht, P. Johnsen, S.P. see Nakagawa, S. Grubb, A. see Dorkhan, M. Jones, P. see Poston, W.S.C. Jorde, R. see Iqbal, A. Haddock, C.K. see Poston, W.S.C. Jorgensen, J.O.L. see Norrelund, H. Halbirk, M. see Norrelund, H. Jovinge, S. see Dorkhan, M. Halkes, S.J.M. see Kruip, M.J.H.A. Jukema, J.W. see Rana, J.S. Hamdy, N.A.T. see Timmers, H.J.L.M. Hammarstrém, L. see Norrby-Teglund, A. Kakoulidou, M. see Giscombe, R. Hansen, J.F. see Sajadieh, A. Karakoc, N. see Poston, W.S.C. Hansson, M. see Milakovic, M. Karperien, M. see Timmers, H.J.L.M. Haque, K.N. see Norrby-Teglund, A. Kastelein, J.J.P. see Rana, J.S. Hedblad, B. see Engstrém, G. Kauma, H. see Poykk6, S.M. Heeney, J.L. Zoonotic viral diseases and the frontier of early Kawaguchi, A. see Inui, T. diagnosis, control and prevention, 399 Kellokoski, E. see Poykk6, S.M. Hein, H.O. see Sajadieh, A. Kesaniemi, Y.A. see P6ykk6, S.M. Henter, J.-I. see Wastfelt, M. Klausen, K.P., Scharling, H. & Jensen, J.S. Very low level of Henyan, N.N., White, C.M., Gillespie, E.L., Smith, K., Coleman, microalbuminuria is associated with increased risk of death C.I. & Kluger, J. The impact of gender on survival amongst in subjects with cardiovascular or cerebrovascular diseases, patients with implantable cardioverter defibrillators for 231 primary prevention against sudden cardiac death, 467 Klima, T. see Mueller, C. Herlitz, J., Svensson, L., Silfverstolpe, J.. Angquist, K.-A., Wisten, Kluger, J. see Henyan, N.N. A., Engdahl, J. & Holmberg, S. Characteristics and outcome Kramer, M.H.H. see Kruip, M.J.H.A. amongst young adults suffering from out-of-hospital cardiac Kremastinos, D.T. see Filippatos, G.S. arrest in whom cardiopulmonary resuscitation is attempted, Kropf, C. see Kriiger, S. 435 Kriiger, S., Buck, A.K., Blumstein, N.M., Pauls, S., Schelzig, H., Hermus, A.R.M.M. see Timmers, H.J.L.M. Kropf, C., Schumann, C., Mottaghy, F.M., Hombach, V. & Hervé, F. see Marie, I. Reske, S.N. Use of integrated FDG PET/CT imaging in Hishikawa, Y. see Inui, T. pulmonary carcinoid tumours, 545 Hjemdahl, P. see Almquist, T. Kruip, M.J.H.A., Sohne, M., Nijkeuter, M., Kwakkel-van Erp, H.M., Ho, C.-K. see Huang, J.-F. Tick, L.W., Halkes, S.J.M., Prins, M.H., Kramer, M.H.H., Hochholzer, W. see Mueller, C. Huisman, M.V., Biiller, H.R. & Leebeek, F.W.G. on behalf of Holmberg, S. see Herlitz, J. the Christopher study investigators. A simple diagnostic Hombach, V. see Kriiger, S. strategy in hospitalized patients with clinically suspected Horkk6, S. see Poykk6, S.M. pulmonary embolism, 459 Hosking, D. see Lips, P. Kujala, S. see Virkkunen, I. Huang, J.-F., Chuang, W.-L., Dai, C.-Y., Ho, C.-K., Hwang, S.-J., Kumar, B. see Singh, V. Chen, S.-C., Lin, Z.-Y., Wang, L.-Y., Chang, W.-Y. & Yu, M.-L. Kurishima, K. see Satoh, H. Viral hepatitis and proteinuria in an area endemic for Kvas, E. see Marschang, P. hepatitis B and C infections: another chain of link?, 255 Kwakkel-van Erp, H.M. see Kruip, M.J.H.A. Huisman, M.V. see Kruip, M.J.H.A. Hulthe, J. see Behre, C.J. Laakso, M. see Smith, U. Hwang, S.-J. see Huang, J.-F. Lagerqvist, B. see Jensen, J. Lagerqvist, B. see Tornvall, P. Inui, A. see Inui, T. Lahaxe, L. see Marie, I. Inui, T., Asakawa, A., Morita, Y., Mizuno, S., Natori, T., Lamprecht, P., Csernok, E. & Gross, W.L. Effector memory T cells Kawaguchi, A., Murakami, M., Hishikawa, Y. & Inui, A. as driving force of granuloma formation and autoimmunity HER-2 overexpression and targeted treatment by trastuzu- in Wegener's granulomatosis, 187 mab in a very old patient with gastric cancer, 484 Lantieri, P.B. see Testa, R. © 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: 601-605 AUTHOR INDEX 603 Larsson, A. see Milakovic, M. Nain, C.K. see Singh, V. Laule-Kilian, K. see Mueller, C. Nakagawa, S., Pedersen, L., Olsen, M.L., Mortensen, P.B., Leebeek, F.W.G. see Kruip, M.J.H.A. Sorensen, H.T. & Johnsen, S.P. Antipsychotics and risk of Lefvert, A.K. see Giscombe, R. first-time hospitalization for myocardial infarction: a popu- Leira, R., Rodriguez-Yanez, M., Castellanos, M., Blanco, M.., lation-based case-control study, 451 Nombela, F., Sobrino, T., Lizasoain, I., Davalos, A. & Natori, T. see Inui, T. Castillo, J. Hyperthermia is a surrogate marker of Nielsen, O.W. see Sajadieh, A. inflammation-mediated cause of brain damage in acute Nijkeuter, M. see Kruip, M.J.H.A. ischaemic stroke, 343 Nilsson, J.-A. see Nilsson, P.M. Levesque, H. see Marie, I. Nilsson, P.M., Nilsson, J.- A. & Berglund, G. Population- Lin, Z.-Y. see Huang, J.-F. attributable risk of coronary heart disease risk Lind, L. see Str6m Moller, C. factorsduring long-term follow-up: the Malmé6 Preventive Lindahl, B. see Claesson, M. Project, 134 Lindahl, B. see Norberg, M. Nilsson, T. see Jensen, J. Lippuner, K. see Lips, P. Nilsson, T. see Tornvall, P. Lips, P., Hosking, D., Lippuner, K., Norquist, J.M., Wehren, L.E., Njaastad, A.M. & Abildgaard, U. Bleeding in patients with Maalouf, G., Ragi-Eis, S. & Chandler, J. The prevalence of mechanical heart valves on warfarin: impact of target INR vitamin D inadequacy amongst women with osteoporosis: an and of comorbidity, 596 international epidemiological investigation, 245 Nombela, F. see Leira, R. Liu, W. see Agarwal, A.K. Norbeck, O. see Broliden, K. Lizasoain, I. see Leira, R. Norberg, M., Eriksson, J.W., Lindahl, B., Andersson, C., Rolands- Loh, P.H., Rigby, A.S. & Cleland, J.G.F. Randomized trials are also son, O., Stenlund, H. & Weinehall, L. A combination of essential for device therapy: reply, 282 HbA Ic, fasting glucose and BMI is effective in screening for Lu, M., Ye, W., Adami, H.-O. & Weiderpass, E. Prospective study of individuals at risk of future type 2 diabetes: OGTT is not body size and risk for stroke amongst women below age 60, needed, 263 442 Norquist, J.M. see Lips, P. Lundasen, T., Galman, C., Angelin, B. & Rudling, M. Circulating Norrby-Teglund, A., Haque, K.N. & Hammarstrém, L. intestinal fibroblast growth factor 19 has a pronounced Intravenous polyclonal IgM-enriched immunoglobulin diurnal variation and modulates hepatic bile acid synthesis in therapy in sepsis: a review of clinical efficacy in relation to man, 530 microbiological aetiology and severity of sepsis, 509 Norrelund, H., Wiggers, H., Halbirk, M., Frystyk, J., Flyvbjerg, A.. Maalouf, G. see Lips, P. Botker, H.E., Schmitz, O., Jorgensen, J.O.L., Christiansen, J.S. Magnusson, M. see Dorkhan, M. & Moller, N. Abnormalities of whole body protein turnover, Mahé, I. see Fontaine, A. muscle metabolism and levels of metabolic hormones in Maiolino, G. see Cesari, M. patients with chronic heart failure, 11 Marie, I., Hervé, F., Lahaxe, L., Robaday, S., Gerardin, E. & Nystrém, E. see Milakovic, M. Levesque, H. Intravenous immunoglobulin-associated cranial pachymeningitis, 164 Marre, R. see Bauer, T.T. Ohtsuka, M. see Satoh, H. Marschang, P., Sandhofer, A., Ritsch, A., Fis“er, I., Kvas, E. & Olsen, M.L. see Nakagawa, S. Patsch, J.R. Plasma cholesteryl ester transfer protein Olsson, A. see Milakovic, M. concentrations predictcardiovascular events in patients with Osswald, S. see Schaer, B.A. coronary artery diseasetreatedwith pravastatin, 151 Mascitelli, L. & Pezzetta, F. Statin treatment, reduced T-cell content of atherosclerotic plaques and cancer, 592 Pace, P. see Poston, W.S.C. Mattsson, C. see Claesson, M. Paivansalo, M. see Péykk6, S.M. Milakovic, M., Berg, G., Eggertsen, R., Nystrom, E., Olsson, A., Patsch, J.R. see Marschang, P. Larsson, A. & Hansson, M. Determination of intrathyroidal Pauls, S. see Kriiger, S. iodine by X-ray fluorescence analysis in 60- to 65-year olds Pedersen, L. see Nakagawa, S. living in an iodine-sufficient area, 69 Pedon, L. see Cesari, M. Milazzo, S. see Testa, R. Perruchoud, A.P. see Mueller, C. Mizuno, S. see Inui, T. Pessina, A.C. see Cesari, M. Moller, N. see Norrelund, H. Pettila, V. see Saukkonen, K.A. Morgenthaler, N.G. see Miiller, B. Pettila, V. see Virkkunen, I. Morita, Y. see Inui, T. Pezzetta, F. see Mascitelli, L. Mortensen, P.B. see Nakagawa, S. Pinkston, M.M. see Poston, W.S.C. Mosekilde, L. see Vestergaard, P. Pittler, M.H. see Ernst, E. Mottaghy, F.M. see Kriiger, S. Poston, W.S.C., Haddock, C.K., Pinkston, M.M., Pace, P., Reeves, Mueller, C., Laule-Kilian, K., Klima, T., Breidthardt, T., Hochhol- R.S., Karakoc, N., Jones, P. & Foreyt, J.P. Evaluation of a zer, W., Perruchoud, A.P. & Christ, M. Right bundle branch primary care-oriented brief counselling interventionfor block and long-term mortality in patients with acute obesity with and without orlistat, 388 congestive heart failure, 421 Pouchain, D. see Bosson, J.-L. Miller, B., Stiess, E., Schuetz, P., Miiller, C., Bingisser, R.., Poykk6, S.M., Kellokoski, E., Ukkola, O., Kauma, H., Paivansalo, Bergmann, A., Stolz, D., Tamm, M., Morgenthaler, N.G. & M., Kesaniemi, Y.A. & Hérkk6, S. Plasma ghrelin concen- Christ-Crain, M. Circulating levels of pro-atrial natriuretic trations are positively associated with carotid artery peptide in lower respiratory tract infections, 568 atherosclerosis in males, 43 Miiller, C. see Miiller, B. Prins, M.H. see Kruip, M.J.H.A. Murakami, M. see Inui, T. Proudfoot, D. see lyemere, V.P. © 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: 601-605 604 AUTHOR INDEX Ragi-Eis, S. see Lips, P. Sorensen, H.T. see Nakagawa, S. Rana, J.S., Jansen, A.C., Zwinderman, A.H., van Aalst-Cohen, Stampfer, M.J. Cardiovascular disease and Alzheimer’s disease: E.S., Jukema, J.W., Trip, M.D. & Kastelein, J.J.P. Lipoprotein common links, 211 (a) and risk of cardiovascular disease in patients Stavem, K., Sandvik, L. & Erikssen, J. Breathlessness, phlegm and withmetabolic syndrome in a population of familial mortality: 26 years of follow-up in healthy middle-aged hypercholesterolaemia, 183 Norwegian men, 332 Rasanen, P. see Saukkonen, K.A. Stegmayr, B. see Eliasson, M. Rasmussen, V. see Sajadieh, A. Stehman-Breen, C. see Agarwal, A.K. Reed, J.E. see Agarwal, A.K. Stenlund, H. see Norberg, M. Reeves, R.S. see Poston, W.S.C. Stettler, C., Suter, Y., Allemann, S., Zwahlen, M., Christ, E.R. & Rehnqvist, N. see Almquist, T. Diem, P. Apolipoprotein B as a long-term predictor of Rejnmark, L. see Vestergaard, P. mortality in type 1 diabetes mellitus: a 15-year follow up, Reske, S.N. see Kriiger, S. 272 Rigby, A.S. see Loh, P.H Sticherling, C. see Schaer, B.A. Risso, D. see Testa, R. Stolz, D. see Miiller, B. Ritsch, A. see Marschang, P. Strém Moller, C., Zethelius, B., Sundstrém, J. & Lind, L. Impact of Robaday, S. see Marie, I. follow-up time and re-measurement of the electrocardiogram Rodriguez-Yanez, M. see Leira, R. and conventional cardiovascular risk factors on their Roine, R.P. see Saukkonen, K.A. predictive value for myocardial infarction, 22 Rolandsson, O. see Norberg, M. Stiess, E. see Miiller, B. Rosenqvist, M. see Tabrizi, F. Sundstrém, J. see Str6m Moller, C. Rossi, G.P. see Cesari, M. Suter, Y. see Stettler, C. Riick, A. & Sylvén, C. Randomized trials are also essential for Suttorp, N. see Bauer, T.T. device therapy, 281 Svensson, L. see Herlitz, J. Rudling, M. see Lundasen, T. Sylvén, C. see Riick, A. Ryynanen, S. see Virkkunen, I. labrizi, F., Rosenqvist, M., Bergfeldt, L. & Englund, A. Long-term Sajadieh, A., Nielsen, O.W., Rasmussen, V., Hein, H.O. & Hansen, prognosis in patients with bifascicular block — the predictive J.P. C-reactive protein, heart rate variability and prognosis in value of noninvasive and invasive assessment, 31 community subjects with no apparent heart disease, 377 Takkouche, B. see Wiens, M. Sandhofer, A. see Marschang, P. Tamm, M. see Miiller, B. Sandvik, L. see Stavem, K. Testa, E. see Testa, R. Sarev, T. see Jensen, J. Testa, R., Testa, E., Giannini, E., Borro, P., Milazzo, S., Isola, L., Satoh, H., Kurishima, K., Ishikawa, H. & Ohtsuka, M. Increased Ceppa, P., Lantieri, P.B. & Risso, D. Noninvasive ratio indexes levels of KL-6 and subsequent mortality in patients with to evaluate fibrosis staging in chronichepatitis C: role of interstitial lung diseases, 429 platelet count/spleen diameter ratio index, 142 Saukkonen, K.A., Varpula, M., Rasénen, P., Roine, R.P., Voipio- Tick, L.W. see Kruip, M.J.H.A. Pulkki, L.-M. & Pettilaé, V. The effect of emergency department Timmers, H.J.L.M., Karperien, M., Hamdy, N.A.T., de Boer, H. & delay on outcome in critically ill medical patients: evaluation Hermus, A.R.M.M. Normalization of serum calcium by using hospital mortality and quality of life at 6 months, 586 cinacalcet in a patient with hypercalcaemia due to a de novo Schaer, B.A., Sticherling, C. & Osswald, S. What are the inactivating mutation of the calcium-sensing receptor, 177 professional and logistic demands to appropriately follow Tolfvenstam, T. see Broliden, K. patients with an implantable cardioverter-defibrillator?, 88 Tornvall, P., Nilsson, T. & Lagerqvist, B. Effects on mortality of Scharling, H. see Klausen, K.P. abciximab in ST-elevation myocardial infarction treated with Schelzig, H. see Kriiger, S. percutaneous coronary intervention including stent implan- Schmitz, O. see Norrelund, H. tation, 363 Schneider, V. see Drevs, J. Tornvall, P. see Jensen, J. Schuetz, P. see Miiller, B. Trip, M.D. see Rana, J.S. Schumann, C. see Kriiger, S. Shanahan, C.M. see lyemere, V.P. Ukkola, O. see Poykk6, S.M. Sharma, A.K. see Singh, V. Sharma, N. see Singh, V. Shepherd, J. Who should receive a statin these days? Lessons from Varma, N. see Agarwal, A.K. recent clinical trials, 305 Varpula, M. see Saukkonen, K.A. Silfvast, T. see Virkkunen, I Vestergaard, P., Rejnmark, L. & Mosekilde, L. Fracture risk Silfverstolpe, J. see Herlitz, J associated with the use of morphine and opiates, 76 Silver, M.R. see Agarwal, A.K. Vinceneux, P. see Fontaine, A. Singh, B. see Singh, V. Virkkunen, I., Kujala, S., Ryynanen, S., Vuori, A., Pettila, V., Yli- Singh, V., Kumar, B., Nain, C.K., Singh, B., Sharma, N., Bhalla, A. Hankala, A. & Silfvast, T. Bystander mouth-te-mouth & Sharma, A.K. Noradrenaline and albumin in paracentesis- ventilation and regurgitation during cardiopulmonary re- induced circulatory dysfunction in cirrhosis: a randomized suscitation, 39 pilot study, 62 Voipio-Pulkki, L.-M. see Saukkonen, K.A. Smith, K. see Henyan, N.N. Vuori, A. see Virkkunen, I. Smith, U., Laakso, M., Eliasson, B., Wesslau, C., Borén, J.. Wiklund, O. & Attvall, S. Pathogenesis and treatment of Wang. L.-Y. see Huang, J.-F. diabetic vascular disease — illustrated by two cases, 409 Wang, X.B. see Giscombe, R. Sobrino, T. see Leira, R. Wastfelt, M., Fadeel, B. & Henter, J.-I. A journey of hope: lessons Séhne, M. see Kruip, M.J.H.A. learned from studies on rare diseases and orphan drugs, 1 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: 601-605 AUTHOR INDEX 605 Wehren, L.E. see Lips, P. Wikstrand, J. see Behre, C.J. Weiderpass, E. see Lu, M. Wisten, A. see Herlitz, J. Weinehall, L. see Norberg, M. Weissberg, P.L. see lyemere, V.P. Ye, W. see Lu, M. Welte, T. see Bauer, T.T. Yli-Hankala, A. see Virkkunen, I. Wesslau, C. see Smith, U. Yu, M.-L. see Huang, J.-F. White, C.M. see Henyan, N.N. Wiens, M., Etminan, M., Gill, $.S. & Takkouche, B. Effects of antihypertensive drug treatments on fracture outcomes: a Zanchetta, M. see Cesari, M. meta-analysis of observational studies, 350 Zethelius, B. see Str6m Moller, C. Wiggers, H. see Norrelund, H. Zwahlen, M. see Stettler, C. Wiklund, O. see Smith, U. Zwinderman, A.H. see Rana, J.S. Wiklund, O. Response by authors, 594 © 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: 601-605 Journal of Internal Medicine 2006; 260 : 606-607 Keyword index abciximab, 363 coronary, 134 inadequacy, 245 acute artery disease, 151, 474 inappropriate ICD therapy, 88 encephalopathy, 164 heart disease, 231 incidence, 134 heart failure, 1 cranial pachymeningitis, 164 infectious disease, 509 stroke, 343 C-reactive protein, 320 inflammation, 377, 509 adiponectin, 125, 238, 474 creatinine clearance, 537 insulin resistance, 320, 474 albumin, 62 critical illness, 586 intensive care units, 586 alcohol, 211 CYP46, 493 internal all-cause mortality, 31 cytokines, 343 carotid artery, 238 Alzheimer’s, 211 medicine, 369 aminopyrine breath test, 142 darbepoetin alfa, 577 interstitial lung disease, 429 anaemia, 577 diabetes, 211, 409 intervention, 369 angina pectoris, 537 diagnosis, 160, 285 intravenous immunoglobulin, 164 angiogenesis, 517 differentiation, 192 iodine, 69 angioplasty, 118 diuretic, 350 antihypertensive, 350 diurnalrhythm, 530 KL-6, 429 antipsychotics, 45] dyspnoea, 332 aapnotlii-ptoupmrooutre,i ns,5 172 2, 272 dysrhythmia, 467 length of stay, 586 ascitis, 62 leptin, 320 aseptic menin-gitis, 164 early diagnosis, 399 lipid metabolism, 11, 53, 530 atherosclerosis, 43, 238 Ebola, 399 liver fibrosis, 142 electrocardiogram, 1, 22 liver function, 142 emerging diseases, 399 longitudinal studies, 22 Bb1e9h,a vi2o8u5r al medicine, 388 eennddooctroixnaoelmoigay,, 50197 7 lowb ack pain, 160 bifascicular block, 31 enterohepatic circulation, 530 density lipoprotein receptor, 305 bile acids, 530 epidemiology, 53, 134, 168, 231, 245, molecular-weight heparin, 168 biomarker, 568 255, 451, 560 lymphocytes, 224 B-blocker, 350 excess mortality, 103 blocker, 350 blood-brain barrier, 4‘ meta-analysis, 350 familial microalbuminuria, 231 hemophagocytic lymphohistio- MONICA, 551 cytosis, 1 morphine, 76 hypocalciuric hyper-calcaemia, 177 mortality, 1, 272, 332 calcification, 192 fibrinolysis, 320 mouth-to-mouth ventilation, calcium-sensing receptor, 17 fitness, 332 muscle metabolism, 11 cancer, 103 forced myocardial ccaarrcdiinaoci d, 545 evixtpail ractaoprayc itvyo, lum5e6,0 560 infaanrcdt iornis,k 4f5ac1t,o rs5, 3 2/ 2 arrest, 39, 435 fracture, 76, 350 ischaemia, 320 electrophysiology, 467 FXR, 530 cardiovascular, 134, 211 death, 537 natriuretic peptides, 568 disease, 560 gastric cancer, 484 nephropathy, 255 disease prevention, 305 glucose metabolism, 11, 263 noradre-naline, 62 NT-proBNP, 125 risk factors, 272 case-control study, 451 27-hydroxy cholesterol, 493 CBFA1, 192 H5N1 flu, 399 obesity, 388, 442, 551 cholesterol, 53, 305, 530, 551 haemoglobin, 577 opiate, 76 cholesteryl ester transfer protein, 151 heart failure, 11 oral therapy, 125 chronic heart rate variability, 377 orphan drugs, | hepatitis C, 142 hepatitis, 255 osteoporotic, 245 kidney disease, 577 HER-2 overexpression, 484 outpatient clinic, 88 cinacalcet, 177 hereditary type I tyrosinemia, 1 oxysterols, 493 cirrhosis, 62 hormones, 43 clinical hospital mortality, 586 paracentesis, 62 examination, 255, 459 hospitalization — mortality, 93 parathyroid, 177 management, 285 hypertension, 474 hormone, 177 coagulation, 459 hyperthermia, 343 parvovirus, 285 cohort, 551 pathogenesis, 285 cohort study, 332, 442 idiopathic interstitial pneumonia, 429 patient advocacy groups, 1 collagen disease, 429 imaging, 517 PCI, 363 community-acquired pneumonia, 93 immunotherapy, 509 peripheral vascular diseases, computed tomography, 459, 545 implantable cardioverter-defibrillator, 88 personalized therapy, 484 © 2006 Blackwell Publishing Ltd KEYWORD INDEX 607 phenotype, 192, 224 restriction fragment length thromboprophylaxis, 369 phlegm, 332 polymorphism, 151 thyroid platelet count/spleen diameter ratio, 142 resuscitation, 39 diseases, 53 pneumonia, 568 revasculari-zation, 118 gland, 69 population-attributable risk, 134 review, 399 transcription factors, 192 positron emission tomography, 545 right bundle branch block, 1 trastuzumab, 484 postmenopausal, 245 risk, 76, 442 triglycerides, 53 pravastatin, 151 factors, 43, 211, 263, 377 tuberculosis, 160 pregnancy, 285 type 1 diabetes mellitus, 272 prehospital, 39 24S-hydroxy-cholesterol, 493 type 2 diabetes, 125 primary care, 168, 388 sepsis, 509 diabetes mellitus, 263 prognosis, 31, 93, 377, 568 severe young adults, 435 acute respiratory syndrome, 399 ultrasound, 238 prognostic factor, 429 combined immunodeficiency, 1 ppprrrooosptphoeyncl taixiovines , brea1an6md8,o mi4z8e4 d trial, 369 sssemmvooekoriittnhyg ,, m9u31s3 c4l,e 5c5el1l s, 192 vvaacscciunleasr, di3s9e9a se, 409 pulmonary embolism, 459 socioeconomy, 551 vvietnaomuisn tDh,r o2m4b5o embolism incidence, 168 soluble markers, 517 quality of life, 586 statins, 305 STEMI, 363 Wegener’s granulomatosis, 224 rraerce omdmiseenadsaest,i on1, 369 sssttuerdnodtk,ee ,n 111c86a 4r,d ia2c3 1,d ea4th4,2 31 Wwweeosimtge-hnNt,i l elo,2s s3,8 3,9 398 382 0 regurgitation, 39 relative survival prognosis, 103 survival, 103 renal failure, 231 analysis, 103 X-ray fluorescence, 69 respiratory symptoms, 332 T-cell receptor, 224 zoonosis, 399 tract infections, 568 thiazide, 350 restenosis, 118 thiazolidinediones, 125 © 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: 606-607 iv VOLUME CONTENTS Plasma cholesteryl ester transfer protein REVIEW ARTICLES concentrations predict cardiovascular events in patients with coronary artery Vascular smooth muscle cell phenotypic disease treated with pravastatin plasticity and the regulation of vascular P. Marschang, A. Sandhofer, A. Ritsch, calcification I. Fiser, E. Kvas & J. R. Patsch V. P. Iyemere, D. Proudfoot, P. L. Weissberg & C. M. Shanahan Spinal tuberculosis: overlooked? S. Abou-Raya & A. Abou-Raya Cardiovascular disease and Alzheimer’s : disease: common links Intravenous immunoglobulin-associated M. J. Stampfer cranial pachymeningitis I. Marie, F. Hervé, L. Lahaxe, S. Robaday, ORIGINAL ARTICLES E. Gerardin & H. Levesque : arr pe Characterization of the expanded T-cell populations in patients with Wegener's A prospective observational study of a cohort granulomatosis of outpatients with an acute medical event R. Giscombe, X. B. Wang, M. Kakoulidou and reduced mobility: incidence of & A. K. Lefvert symptomatic thromboembolism and description of thromboprophylaxis practices 168 ‘ Be een J.-L. Bosson, D. Pouchain & J.-F. Bergmann Very low level of microalbuminuria ee. for The ETAPE Study Group associated with increased risk of death in , subjects with cardiovascular or Sate = cerebrovascular diseases CASE REPORT K. P. Klausen, H. Scharling Normalization of serum calcium by cinacalcet & J. S. Jensen in a patient with hypercalcaemia due to a de novo inactivating mutation of the Are serum adiponectin concentrations in a calcium-sensing receptor population sample of 64-year-old Caucasian H. J. L. M. Timmers, M. Karperien, women with varying glucose tolerance N. A. T. Hamdy, H. de Boer & associated with ultrasound-assessed A. R. M. M. Hermus atherosclerosis? C. J. Behre, G. Brohall, J. Hulthe, J. Wikstrand LETTER TO THE EDITOR & B. Fagerberg Lipoprotein (a) and risk of cardiovascular The prevalence of vitamin D inadequacy disease in patients with metabolic syndrome amongst women with osteoporosis: an in a population of familial hypercholester- international epidemiological investigation olaemia 183 P. Lips, D. Hosking, K. Lippuner, J. S. Rana, A. C. Jansen, A. H. Zwinderman, J. M. Norquist, L. E. Wehren, G. Maalouf, E. S. van Aalst-Cohen, J. W. Jukema, S. Ragi-Eis & J. Chandler M. D. Trip & J. J. P. Kastelein Viral hepatitis and proteinuria in an area ERRATUM endemic for hepatitis B and C infections: another chain of link? J.-F. Huang, W.-L. Chuang, C.-Y. Dai, C.-K. Ho, S.-J. Hwang, S.-C. Chen, Z.-Y. Lin, L.-Y. Wang, W.-Y. Chang & M.-L. Yu NO. 3, September 2006 A combination of HbA Ic, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not Effector memory T cells as driving force of needed granuloma formation and autoimmunity in M. Norberg, J]. W. Eriksson, B. Lindahl, Wegener's granulomatosis C. Andersson, O. Rolandsson, H. Stenlund P. Lamprecht, E. Csernok & L. Weinehall & W. L. Gross 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: iii-vii VOLUME CONTENTS Apolipoprotein B as a long-term predictor Effects on mortality of abciximab in of mortality in type 1 diabetes mellitus: ST-elevation myocardial infarction treated a 15-year follow up with percutaneous coronary intervention C. Stettler, Y. Suter, S. Allemann, M. Zwahlen, including stent implantation E. R. Christ & P. Diem P. Tornvall, T. Nilsson & B. Lagerqvist LETTER TO THE EDITOR Effectiveness of written guidelines on the appropriateness of thromboprophylaxis Randomized trials are also essential for device prescriptions for medical patients: therapy a prospective randomized study A. Riick & C. Sylvén A. Fontaine, I. Mahé, J. F. Bergmann, J. N. Fiessinger, R. Dhote, P. Cohen Randomized trials are also essential for device & P. Vinceneux therapy: reply P. H. Loh, A. S. Rigby & J. G. F. Cleland C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease A. Sajadieh, O. W. Nielsen, V. Rasmussen, H. O. Hein & J. F. Hansen Evaluation of a primary care-oriented brief NO. 4, October 2006 counselling intervention for obesity with and without orlistat W. S. C. Poston, C. K. Haddock, REVIEW ARTICLES M. M. Pinkston, P. Pace, R. S. Reeves, N. Karakoc, P. Jones & J. P. Foreyt Clinical aspects of parvovirus B19 infection K. Broliden, T. Tolfvenstam & O. Norbeck Who should receive a statin these days? Lessons from recent clinical trials J. Shepherd NO. 5, November 2006 ORIGINAL ARTICLES Cognitive-behavioural stress management REVIEW ARTICLES does not improve biological cardiovascular risk indicators in women with ischaemic Zoonotic viral diseases and the frontier of heart disease: a randomized-controlled trial early diagnosis, control and prevention M. Claesson, L. S. Birgander, J.-H. Jansson, J. L. Heeney B. Lindahl, G. Burell, K. Asplund & C. Mattsson Pathogenesis and treatment of diabetic vascular disease — illustrated by two cases Breathlessness, phlegm and mortality: 26 U. Smith, M. Laakso, B. Eliasson, C. Wesslau, years of follow-up in healthy middle-aged J. Borén, O. Wiklund & S. Attvall Norwegian men K. Stavem, L. Sandvik & J. Erikssen ORIGINAL ARTICLES Hyperthermia is a surrogate marker of Right bundle branch block and long-term inflammation-mediated cause of brain mortality in patients with acute congestive damage in acute ischaemic stroke heart failure R. Leira, M. Rodriguez-Yanez, M. Castellanos, C. Mueller, K. Laule-Kilian, T. Klima, M. Blanco, F. Nombela, T. Sobrino, T. Breidthardt, W. Hochholzer, I. Lizasoain, A. Davalos & J. Castillo A. P. Perruchoud & M. Christ Effects of antihypertensive drug treatments on Increased levels of KL-6 and subsequent fracture outcomes: a meta-analysis of mortality in patients with interstitial lung observational studies diseases M. Wiens, M. Etminan, S. S. Gill H. Satoh, K. Kurishima, H. Ishikawa & B. Takkouche & M. Ohtsuka © 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: iii—vii vi VOLUME CONTENTS Characteristics and outcome amongst young NO. 6, December 2006 adults suffering from out-of-hospital cardiac arrest in whom cardiopulmonary resuscitation is attempted REVIEW ARTICLES ]. Herlitz, L. Svensson, J. Silfverstolpe, K.-A. Angquist, A. Wisten, J. Engdahl Crossing the barrier: oxysterols as cholesterol & S. Holmberg transporters and metabolic modulators in the brain Prospective study of body size and risk for I. Bjorkhem stroke amongst women below age 60 M. Lu, W. Ye, H.-O. Adami & E. Weiderpass Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review Antipsychotics and risk of first-time of clinical efficacy in relation to hospitalization for myocardial infarction: microbiological aetiology and severity of a population-based case-control study sepsis S. Nakagawa, L. Pedersen, M. L. Olsen, A. Norrby-Teglund, K. N. Haque P. B. Mortensen, H. T. Sorensen & L. Hammarstrom & S. P. Johnsen The use of vascular biomarkers and A simple diagnostic strategy in hospitalized imaging studies in the early clinical patients with clinically suspected development of anti-tumour agents pulmonary embolism targeting angiogenesis M. J. H. A. Kruip, M. Sohne, M. Nijkeuter, J]. Drevs & V. Schneider H. M. Kwakkel-van Erp, L. W. Tick, S. J. M. Halkes, M. H. Prins, RAPID COMMUNICATION M. H. H. Kramer, M. V. Huisman, H. R. Biiller & F. W. G. Leebeek on behalf of Circulating intestinal fibroblast growth factor the Christopher study investigators 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in The impact of gender on survival amongst man patients with implantable cardioverter T. Lundasen, C. Gélman, B, Angelin defibrillators for primary prevention against & M. Rudling sudden cardiac death 467 N. N. Henyan, C. M. White, E. L. Gillespie, ORIGINAL ARTICLES K. Smith, C. I. Coleman & J. Kluger Prognostic implications of renal dysfunction in patients with stable angina pectoris Low plasma adiponectin is associated with T. Almquist, L. Forslund, N. Rehngqvist coronary artery disease but not with é> P. Hjemdahl hypertension in high-risk nondiabetic cet A. C. Pessina, M. Zanchetta, Use of integrated FDG PET/CT imaging in R. De Toni, A. Avogaro, L. Pedon, F. Dorigatti, pulmonary carcinoid apps Midas OC P. Rossi : S. Krtiger, A. K. Buck, N. M. Blumstein, S. Pauls, H. Schelzig, C. Kropf, C. Schumann, CASE REPORT F. M. Mottaghy, V. Hombach & S. N. Reske HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with Time trends in population cholesterol levels gastric cancer 484 1986-2004: influence of lipid-lowering T. Inui, A. Asakawa, Y. Morita, S. Mizuno, drugs, obesity, smoking and educational T. Natori, A. Kawaguchi, M. Murakami, level. The northern Sweden MONICA study Y. Hishikawa & A. Inui M. Eliasson, U. Janlert, J.-H. Jansson & B. Stegmayr LETTER TO THE EDITOR Reduced lung function predicts increased Efficacy or effectiveness? fatality in future cardiac events. E. Ernst & M. H. Pittler a population-based study G. Engstrém, B. Hedblad Erratum é> L. Janzon 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: iii-vii